Study of Anlotinib Plus Chemotherapy as the First-line Treatment in Patients With Advanced NSCLC
Clinical trial NCT03636685 · UNKNOWN
Trial details
- NCT number
- NCT03636685
- Sponsor
- Chinese Academy of Medical Sciences
- Status
- UNKNOWN
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-08-15
- Primary completion
- 2019-08-14
- Enrollment
- 60
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.